Accuray Inc (ARAY)
1.795
+0.04
(+2.57%)
USD |
NASDAQ |
Nov 04, 13:13
Accuray Enterprise Value: 279.05M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 279.05M |
| October 31, 2024 | 277.05M |
| October 30, 2024 | 292.09M |
| October 29, 2024 | 290.08M |
| October 28, 2024 | 291.09M |
| October 25, 2024 | 279.05M |
| October 24, 2024 | 279.05M |
| October 23, 2024 | 279.05M |
| October 22, 2024 | 281.06M |
| October 21, 2024 | 289.08M |
| October 18, 2024 | 293.09M |
| October 17, 2024 | 287.08M |
| October 16, 2024 | 294.10M |
| October 15, 2024 | 291.09M |
| October 14, 2024 | 284.07M |
| October 11, 2024 | 287.08M |
| October 10, 2024 | 283.07M |
| October 09, 2024 | 280.06M |
| October 08, 2024 | 288.08M |
| October 07, 2024 | 292.09M |
| October 04, 2024 | 295.10M |
| October 03, 2024 | 281.06M |
| October 02, 2024 | 281.06M |
| October 01, 2024 | 276.05M |
| September 30, 2024 | 284.07M |
| Date | Value |
|---|---|
| September 27, 2024 | 283.07M |
| September 26, 2024 | 279.05M |
| September 25, 2024 | 274.04M |
| September 24, 2024 | 281.06M |
| September 23, 2024 | 281.06M |
| September 20, 2024 | 277.05M |
| September 19, 2024 | 294.10M |
| September 18, 2024 | 295.10M |
| September 17, 2024 | 294.10M |
| September 16, 2024 | 322.17M |
| September 13, 2024 | 323.17M |
| September 12, 2024 | 316.15M |
| September 11, 2024 | 301.11M |
| September 10, 2024 | 307.13M |
| September 09, 2024 | 305.12M |
| September 06, 2024 | 296.10M |
| September 05, 2024 | 303.12M |
| September 04, 2024 | 306.13M |
| September 03, 2024 | 315.15M |
| August 30, 2024 | 322.01M |
| August 29, 2024 | 322.01M |
| August 28, 2024 | 326.02M |
| August 27, 2024 | 338.04M |
| August 26, 2024 | 327.02M |
| August 23, 2024 | 332.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.57M
Minimum
Mar 24 2020
627.73M
Maximum
Nov 04 2021
375.39M
Average
361.27M
Median
Dec 05 2019
Enterprise Value Benchmarks
| Boston Scientific Corp | 131.03B |
| Baxter International Inc | 29.17B |
| AngioDynamics Inc | 221.24M |
| Masimo Corp | 8.324B |
| Perspective Therapeutics Inc | 524.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.387M |
| Revenue (Quarterly) | 134.29M |
| Total Expenses (Quarterly) | 127.47M |
| EPS Diluted (Quarterly) | 0.03 |
| Gross Profit Margin (Quarterly) | 28.63% |
| Profit Margin (Quarterly) | 2.52% |
| Earnings Yield | -8.91% |
| Operating Earnings Yield | 0.29% |
| Normalized Earnings Yield | -7.954 |